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Abstract
Background: Enteroendocrine cells collectively constitute our largest endocrine tissue, with serotonin (5-HT)
secreting enterochromaffin (EC) cells being the largest component (~50 %). This gut-derived 5-HT has multiple
paracrine and endocrine roles. EC cells are thought to act as nutrient sensors and luminal glucose is the major
absorbed form of carbohydrate in the gut and activates secretion in an array of cell types. It is unknown whether
EC cells release 5-HT in response to glucose in primary EC cells. Furthermore, fasting augments 5-HT synthesis and
release into the circulation. However, which nutrients cause fasting-induced synthesis of EC cell 5-HT is unknown.
Here we examine the effects of acute and chronic changes in glucose availability on 5-HT release from intact tissue
and single EC cells.
Methods: We utilised established approaches in our laboratories measuring 5-HT release in intact mouse colon with
amperometry. We then examined single EC cells function using our published protocol in guinea-pig colon. Single cell
Ca2+ imaging and amperometry were used with these cells. Real-time PCR was used along with amperometry, on
primary EC cells cultured for 24 h in 5 or 25 mM glucose.
Results: We demonstrate that acute increases in glucose, at levels found in the gut lumen rather than in plasma,
trigger 5-HT release from intact colon, and cause Ca2+ entry and 5-HT release in primary EC cells. Single cell
amperometry demonstrates that high glucose increases the amount of 5-HT released from individual vesicles as they
undergo exocytosis. Finally, 24 h incubation of EC cells in low glucose causes an increase in the transcription of the
5-HT synthesising enzyme Tph1 as well as increasing in 5-HT secretion in EC cells.
Conclusions: We demonstrate that primary EC cells respond to acute changes in glucose availability through increases
in intracellular Ca2+ the activation of 5-HT secretion, but respond to chronic changes in glucose levels through the
transcriptional regulation of Tph1 to alter 5-HT synthesis.
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Background
Enteroendocrine cells collectively constitute our largest
endocrine tissue, made up of cells that are dispersed
throughout the GI tract epithelium. There are multiple
different enteroendocrine cell types, each synthesizing
different hormones, with some containing multiple
hormones [1, 2]. Almost all our body’s 5-HT is synthe-
sized in enteroendocrine cells called enterochromaffin
(EC) cells [3]. 5-HT plays a crucial role in enteric neuro-
transmission, the propagation of intrinsic enteric reflexes,
multiple gastrointestinal disorders and a range of homeo-
static mechanisms [4, 5]. EC cells supply all our circulating
5-HT and recent evidence has demonstrated that plasma
5-HT is essential for metabolic homeostasis [6] and obesity
[7, 8]. However, despite the important physiological
roles of 5-HT, the mechanisms by which EC cell
5-HT release is controlled remains poorly understood.
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Due to their location, enteroendocrine cells are ex-
posed to a unique environment, including ingested nu-
trients. Luminal glucose plays an important role in the
GI tract, where concentrations up to 200–300 mM are
estimated to exist across the luminal brush border mem-
brane after a meal [9]. Glucose is the major form of
absorbed carbohydrate and acts as a signal for the acti-
vation of many regulatory events. The presence of glu-
cose in the intestinal lumen stimulates a number of
changes in GI function including inhibition of both gas-
tric emptying [10] and food intake [11] and stimulation
of pancreatic secretion [12]. There is also evidence that
activation of extrinsic vagal afferent neurons by intes-
tinal glucose can be mediated by release of endogenous
5-HT and activation of 5-HT3 receptors located on vagal
afferent nerve terminals [10, 13], which subsequently
slows gastric emptying and reduces food intake [11].
It is currently unknown whether glucose itself acts
directly on primary EC cells or activates 5-HT release
via secondary mechanisms involving other cell types,
such as through gut contraction, in the intact tissue
preparations used [14, 15]. BON cells, a cell line derived
from a metastatic human carcinoid tumour of the pan-
creas, are responsive to relatively high levels of glucose
(50–75 mM) [16]. However, as these are not primary
EC cells and are derived from the pancreas, where
no EC cells exist, it is not known how closely BON
cell function represents EC cell function. Moreover
evidence that 2-deoxyglucose triggers 5-HT release
from human ileal EC cells {Kidd, 2008 #2007} should
be interpreted with caution, as this glucose analogue
can inhibit cell glycolysis. Accordingly, it is essential to
investigate whether luminal glucose has a direct effect on
EC cell 5-HT release.
Nutrients not only trigger 5-HT release post-prandially,
they may also have more chronic effects on 5-HT synthe-
sis. Fasting was recently demonstrated to augment plasma
5-HT levels through a mechanism involving the increased
expression of Tph1, the rate-limiting enzyme in EC
cell 5-HT synthesis [6]. However which nutrient
changes are involved in this fasting-induced increase
in 5-HT synthesis remains unknown. In this study
we approach the key questions of whether acute and
chronic changes in glucose availability affect EC cell
5-HT release using primary EC cells and intact tis-
sue. We find that glucose levels of 100 mM are re-
quired to trigger EC cell 5-HT release, that this
causes Ca2+ entry in primary EC cells, and that the
mechanism of action involves a significant increase
in the amount of 5-HT released from individual
vesicles. We also observe that chronic changes in
glucose availability (24 h) alter 5-HT release via a
different mechanism involving the transcription of
Tph1 and 5-HT synthesis and release.
Methods
Primary culture and purification of EC cells
Guinea pigs (350–500 g) were euthanized humanely by
stunning with a blow to the head followed by severing of
the carotid arteries, as approved by the Animal Welfare
Committee at Flinders University. EC cell isolation was
undertaken as previously described [17]. 4–6 cm of
distal colon tissue was removed and a midline incision
made along the lining of the colon and then pinned
mucosal-side uppermost in a dish containing Krebs solu-
tion (in mM: 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10
Hepes, 5 D-glucose, pH 7.4. The mucosal layer was
scraped off, minced and centrifuged at 1000 × g for
5 min. The tissue was digested with 0.05 % Trypsin-
EDTA (Sigma Aldrich USA) containing 1 mg/ml Colla-
genase A (Roche Diagnostics Germany) at 37 °C for
30 min with continuous agitation. The reaction was then
stopped by adding an equal volume of growth medium
(DMEM containing 10 % FBS, 1 % L-glutamine and 1 %
penicillin–streptomycin, Sigma Aldrich USA) The sus-
pension was filtered through a 40 μm filter and centri-
fuged at 1000 × g for 5 min and the resulting pellet was
resuspended in 1 ml of growth medium. Density gradi-
ent centrifugation was then performed to separate differ-
ent cell populations in order to purify EC cells. The
density gradient was created by layering Percoll solutions
of varying densities with the dense end at the bottom of
the tube (according to manufacturer’s instructions). The
cell fraction was then layered on top of the Percoll dens-
ity gradient. Centrifugation was performed at 1100 × g
for 8 min with slow braking. EC cells were harvested at
a density of 1.07 g/ml, and then washed once with
growth medium and plated into 6 cm2 pre-treated cell
culture dishes (Iwaki, Australia). EC cells were main-
tained in growth medium for 2–4 days at 37 °C.
Immunocytochemistry
EC cells were grown for 24 h on glass coverslips pre-
treated with 10 μg/ml of poly-d-lysine (Sigma Aldrich
USA) in growth medium. Cells were fixed for 18–20 h in
Zamboni’s fixative at 4 °C followed by serial 5 min washes:
4 × 80 % EtOH, 2 × 100 % EtOH, 3 × DMSO, 4 × PBS.
Fixed cells were incubated for 30 min in 10 % normal
donkey serum diluted in antibody diluent (290 mM NaCl,
7.5 mM Na2HPO4, 2.6 mM Na2HPO4.2H2O, 0.1 % NaN3
in distilled water, pH 7.1) at room temperature. Cells were
then incubated with a goat monoclonal antibody against
5-HT (Jackson Immunoresearch USA, 1:750 in antibody
diluent) for 24 h at room temperature in a humid cham-
ber. After 3 × 5 min washes with PBS, the cells were incu-
bated with donkey anti-goat IgG tagged to the fluorescent
label Cy3 (Jackson Immunoresearch USA, 1:200 in
antibody diluent) and the nuclear marker DAPI (Sigma
Aldrich USA, 1:500) for 2 h at room temperature in a
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humid chamber. After 3 × 5 min washes with PBS, the
coverslips were mounted onto glass slides in buffered gly-
cerol. Fluorescence was visualised on an Olympus BX50
Fluorescence Imaging Microscope under 40x magnifica-
tion. Fluorescence was shown as an overlay of Cy3 (green)
and DAPI (blue) fluorescence.
Calcium imaging
Ca2+ imaging was undertaken as previously reported
[18]. EC cells were treated with Fluo-4 AM (4 μM) in
Krebs solution for 30 min at 37 °C. Cells were main-
tained in Krebs solution and stimulated with Krebs solu-
tion containing either, 100 mM K+, 100 mM Glucose,
20 mM Glucose or 10 μM Acetylcholine. Calcium influx
was visualised as increases in cell fluorescence on a Cas-
cade II fluorescent microscope (Photometrix, USA). Re-
sults were analysed on Imaging Workbench software
(version 6.0.22) (INDEC BioSystems, Inc, USA).
Amperometric measurement of 5-HT release in single cells
5-HT release from single EC cells was measured using
amperometry [19–21]. A carbon-fibre electrode (5-μm
diameter, ProCFE, Dagan Corporation, USA) was placed
one micron above a single EC cell. 400 mV was applied
to the electrode and the current caused by the oxidation
of 5-HT was recorded using an EPC-9 amplifier and
Pulse software (HEKA Electronic, Germany). Krebs solu-
tion was the standard bath solution and the temperature
was controlled using an automatic temperature control-
ler at 34 °C–36 °C (TC-344B; Warner Instrument Cor-
poration, Hamden, CT). All solutions were applied to
cells using a gravity perfusion system. Single EC cells
were perfused with Krebs solution for 30 s then
stimulated for 60 s with Krebs containing 70 mM KCl
(replacing an equimolar amount of NaCl).
Measurement of 5-HT release in intact tissue
The distal colon was removed from C57/Bl6 mice and
placed in Krebs solution oxygenated with 95 % O2, 5 %
CO2. A midline incision was made along the lining of
the colon and then was pinned mucosal-side uppermost
in Sylgard-lined organ bath containing oxygenated Krebs
solution. The colon was placed mucosa uppermost in
Sylgard-lined gel in an organ bath and was continuously
perfused with oxygenated Krebs solution. The temperature
was controlled using an automatic temperature controller
at 34 °C–36 °C (TC-344B; Warner Instrument Corporation,
Hamden, CT). Serotonin release was measured in intact tis-
sue using amperometry as previously described [22, 23]. A
carbon-fibre electrode (5-μm diameter, ProCFE; Dagan
Corporation, Minneapolis, MN), was lowered a few mi-
crons above the epithelial layer to avoid contact with the
tissue surface or mucosa during contractions, there-
fore 5-HT release would not be stimulated by the
electrode compressing the tissue. 400 mV was applied
to the electrode and the current caused by the oxidation
of 5-HT was recorded using an EPC-7 amplifier and Pulse
software (HEKA Electronic, Lambrecht/Pfalz, Germany),
sampled at 10 kHz and low-pass filtered at 1 kHz. Secre-
tion events were determined as events in which the ampli-
tude increased more than 10 times the root-mean-squared
noise of the baseline. Amplitude of each event was taken
as the current size of the peak relative to baseline. Record-
ings and analysis were undertaken in a paired fashion to
minimise potential variance between different tissue prep-
arations or over time. Thus, we analysed the effect under
control (10 mM glucose) and then experimental (30,
50 or 100 mM glucose) and compared this statisti-
cally to their own control data run, prior to each high
glucose exposure.
Measurement of Tph1 expression in guinea pig EC cells
Guinea pig EC cells were purified as described above
and grown in plates for 24 h in growth medium contain-
ing either 25 mM or 5 mM glucose. Cells were harvested
and washed once with DMEM containing no glucose.
Total RNA was extracted using the RNeasy Mini kit
(Qiagen Australia) according to manufacturer’s instruc-
tions. RNA quality was analysed on a Nanodrop1000
spectrophotometer and samples were only used if the
A260/A280 ratio was greater than1.9. cDNA was prepared
from the RNA samples using the Omniscript RT kit
(Qiagen Australia) and random hexamers (Life Tech-
nologies Australia) according to manufacturer’s instruc-
tions. qPCR was carried out using a Quantitect SYBR
Green kit (Qiagen Australia) on a Rotorgene 3000 ac-
cording to manufacturer’s instructions as previously
described [24]. Samples were run in triplicate and data
from at least 3 different cell cultures was analysed using
the REST-RG spreadsheet [25]. Results were normalized to
18S rRNA as a housekeeping gene. Primers for the qPCR
were designed using using the PrimerQuest Online
Primer Design tool (Integrated DNA Technologies, http://
www.idtdna.com/Scitools/Applications/Primerquest/) and
independently confirmed the results using Primer-BLAST
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi).
Primers used were (5’-3’): TPH1 (F-TTGGTTTGTGC
AAGCAGGAC, R-AGTGGAGGTTGGAGTTCACTG)
AND 18S rRNA (F-TGCATGGCCGTTCTTAGTTG,
R-AGTTAGCATGCCAGAGTCTCGTT).
Amperometry measurements and statistics
Amperometry files were converted to Axon Binary Files
(ABF Utility, version 6.0.1, Synaptosoft, USA) and secretory
spikes were analysed (Mini Analysis, version 6.0.1, Synap-
tosoft, USA) from before and during stimulation [26, 27].
Amperometric spikes were selected for analysis of
event frequency if spike amplitude exceeded 10 times
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root-mean-squared noise of the baseline. Rise time of
each spike was calculated from the 50–90 % rising phase.
The number of each individual spike per second before
and during stimulation was measured in Hz. Data in the re-
sults section are present as mean ± S.E.M. The number of
molecules of 5-HT (N) released per exocytotic event from
single cells was calculated using the formula N =Q/nF
where Q is the charge in coulombs, n is the number of
electrons donated by 5-HT upon oxidation and F is the
Faraday constant in Coulombs [28].
Statistical analysis
Differences were considered statistically significant when
P <0.05. A paired t-test was used to compare individual
data sets from the same sample. Unpaired t–tests were
used to analyse data from single cell recordings. A Mann–
Whitney test was used to compare non-parametric spike
analysis data.
Results and discussion
High glucose causes 5-HT release in intact colonic tissue
preparations
We utilised amperometry to measure 5-HT secretion in
real-time in mouse colonic tissue strips to identify
whether glucose can induce 5-HT release from EC cells
lining the gut wall. Mice were used because they main-
tain regular colonic migrating motor complex (CMMC)
activity and cyclical 5-HT release [22, 23] and CMMCs
are less commonly recorded in vitro in other species such
as guinea-pigs and rats. Under control conditions, in the
presence of 10 mM glucose, we observe a frequency of 5-
HT release events of ~0.5 min−1 (Fig. 1a). Increasing the
external glucose to 100 mM causes a rapid increase in re-
lease frequency and amplitude of these release events
(Fig. 1b). These changes in release frequency (Fig. 1c) and
amplitude (Fig. 1d) were only significant at 100 mM glu-
cose, with no changes seen at 20 or 50 mM.
Acute exposure to high glucose causes Ca2+ entry in
single EC cells
Intact gut tissue comprises a complex mix of different
cell types including muscle, neurons, epithelial cells and
endocrine cells. To examine the glucose-response in EC
cells specifically, we utilised EC cells isolated from
guinea-pig colon, a species and approach in which we
had developed and established reliable EC cell output
[17]. Using this approach we are able to isolate an al-
most pure population of EC cells (Fig. 2). We first per-
formed Ca2+ imaging experiments on these cells to
identify whether high glucose causes Ca2+ entry, the
classical trigger of secretion in endocrine cells. As we
know that high K+ and acetylcholine both trigger 5-HT
release in these cells [17], we used these first as positive
controls. We observed clear increases in intracellular
Ca2+ upon exposure to high K+ (Fig. 3a) and acetylcholine
(Fig. 3b). We also observed increased Ca2+ entry upon
exposure to 100 mM glucose (Fig. 3c), but no signifi-
cant Ca2+ increase is seen in 20 mM glucose (Fig. 3d).
Acute exposure to high glucose augments 5-HT release
from single EC cell vesicles
We next examined whether 5-HT secretion is increased
in high glucose in our purified EC cell cultures. To do
this we employed single cell amperometry, which allows
us to resolve 5-HT release from individual vesicles under
various conditions. Not only can we quantify the rate of
vesicle exocytosis, we are also able to measure aspects of
vesicle release (Fig. 4a) including the amount of 5-HT
released per exocytosis event, which is measured as
spike area. Given that 100 mM glucose causes 5-HT re-
lease in intact colon and Ca2+ entry in single EC cells,
we measured whether it increases 5-HT secretion using
single cell amperometry. Increasing external glucose
from 10 mM to 100 mM causes an increase in 5-HT
output (Fig. 4b). This is not due to an increase in the
number of vesicles undergoing exocytosis (Fig. 4c), but
rather to an increase in the amount of 5-HT being re-
leased per exocytosis event, as demonstrated by the sig-
nificant increase in amperometric spike area (Fig. 4d)
and amplitude (Fig. 4e). Thus, acute increases in glucose
availability, at concentrations that would be observed
post-meal, but not in circulation, trigger Ca2+ entry and
5-HT secretion in EC cells.
Chronic exposure to fasting-associated levels of glucose
increases Tph1 transcription and 5-HT release
It has recently been demonstrated that EC cell 5-HT is
augmented during periods of fasting [6], however the
identity of the nutrients associated with this change re-
main unknown. To identify whether reduced glucose
availability may play some part in this fasting response,
we incubated EC cells in concentrations that are equiva-
lent to low (5 mM) or high blood glucose (25 mM) for
24 h to identify whether this alters 5-HT synthesis and
secretion. We find that under these conditions, Tph1
gene expression is significantly higher under low glucose
conditions that mimic fasting (Fig. 5a). This resulted in a
significant increase in both the frequency of 5-HT re-
lease events measured using amperometry (Fig. 5b) as
well as the total number of molecules of 5-HT being re-
leased from each cell (Fig. 5c). Thus, chronically reduced
glucose availability causes an increase in 5-HT synthesis
due to effects on Tph1 expression.
In this study we studied two aspects of enterochromaf-
fin cell function; the nature of both the acute and
chronic response to increased glucose availability. We
demonstrate using intact tissue preparations and single
cell approaches that acute increases in glucose, at levels
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found in the gut lumen rather than in plasma, trigger
Ca2+ entry and 5-HT secretion in EC cells. Furthermore,
this increased 5-HT release occurs through an increase
in the amount of 5-HT released from vesicles in each
exocytosis event. The effects of a more chronic exposure
to high glucose, this time at levels akin to those
observed in plasma post-prandially, cause a reduction in
the synthesis and release of EC cell 5-HT. Thus EC cells
respond in a diverse manner to different glucose
concentrations over different periods of time to either
increase or suppress 5-HT output.
Our data in intact colon tissue is the first ex vivo
demonstration that EC cells are glucose-sensing cells. This
is in agreement with earlier findings in BON cells that only
Fig. 2 Purification of guinea pig EC cells from the colon. (a) bright field image of two primary EC cells in culture, (b) fluorescent image of the
nuclear stain, DAPI, (c) 5-HT labelling, (d) merged image of 5-HT staining and DAPI. Scale bar = 4 μm. (e) Percentage of 5-HT positive cells in our
cultures (n = 3 independent cell cultures)
Fig. 1 Amperometric recordings of 5-HT from intact colon. A continuous real time amperometry recording of 5-HT release in intact colon in the
presence of (a) 10 mM glucose and (b) 100 mM Glucose. Scale bars represent 20 pA and 50 s. 100 mM glucose increases both (c) the frequency
and (d) the size of 5-HT release events (n = 4, **P <0.05)
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concentrations approaching 100 mM glucose are able
to elicit EC cell 5-HT release [16]. Certainly glucose
infusion can alter gut motility [29, 30], and release of
5-HT in these conditions would align with the demon-
strated effects of EC cell 5-HT as a modulator of gut
motility [22, 23]. The fact that no response to 20 or 50 mM
glucose was observed is in agreement with previous
findings [16] and demonstrates that increases in plasma
glucose levels are not sufficient to trigger this acute re-
sponse. Rather, post-prandial levels of luminal glucose,
Fig. 3 Depolarisation increases intracellular levels in EC cells. Example trace from a single EC cell representing calcium entry upon stimulation
with (a) 100 mM K+, (b) 10 μM ACh, (c) 100 mM glucose as indicated with the dashed line. (d) Average EC cell fluorescence change in response
to 100 mM K+ (n = 13 cells), 10 μM ACh (n = 13 cells), 100 mM glucose (n = 15 cells) and 20 mM glucose (n = 7 cells)
Fig. 4 Amperometry demonstrates that high glucose increases the quantal release of 5-HT from single EC cells. (a) A single amperometric spike
indicating the different assessable parameters including the amplitude, area, rise-time and half-width. (b) An example amperometric trace before
and during stimulation with 100 mM glucose (dashed line). Each spike represents 5-HT release from a single vesicle. (c) The frequency of vesicles
releasing 5-HT is unchanged by high glucose but the spike (d) area and (e) amplitude are both increased. n = 8 cells per group. ** p < 0.01
Zelkas et al. Nutrition & Metabolism  (2015) 12:55 Page 6 of 9
estimated to be 200–300 mM [9], will be the only possible
source of glucose capable of triggering 5-HT secretion from
EC cells. Given that gut contraction is capable also of
triggering EC cell 5-HT release [22, 23], we turned to a
primary EC cell culture approach to determine if these ef-
fects of high glucose are through direct effects on EC cells.
We have replicated our previous work in which we
demonstrated EC cell isolation in guinea-pig colon [17].
Indeed in this study we also observe an almost complete
purification of EC cells. This enabled us to undertake
Ca2+ imaging studies with the knowledge that all cells
included in our analysis are EC cells. We observe a
significant increase in Ca2+ entry upon exposure to
100 mM, but not 20 mM, glucose in line with our 5-HT
secretion measurements from whole tissue. Additionally,
our single cell amperometry data confirms 5-HT secre-
tion in response to 100 mM glucose. The mechanism by
which this increase occurs is somewhat surprising. Ra-
ther than observing an increase in the number of release
events, we observe an increased quantal size of individ-
ual release events. Given the rapid nature of this re-
sponse, this is unlikely to be an effect on vesicle loading,
but rather due to an increase in either the size or open
time of the exocytosis fusion pore which can be modu-
lated by various factors [31–33].
We have previously demonstrated that the EC cell
likely contains a smaller, or more rapidly closing, fusion
pore that would explain the vastly lower amount re-
leased during individual release events [17]. This aug-
mentation of quantal release is a novel mechanism of
exocytosis activation that has been linked in other endo-
crine cells to activation of G-protein coupled receptors
and second messenger signalling through PKC [34].
Whether this is the pathway activating 5-HT release in
response to high glucose in EC cells remains unknown
but certainly a large number of fusion pore modulators
exist in endocrine cells including proteins linked to both
exocytosis and endocytosis [31, 35], second messengers
[36, 37] and lipids [35]. The increase in quantal release
we observed could not be attributed to increased 5-HT
loading into vesicles because the response was instantan-
eous, in contrast to the longer time base needed to load
vesicles.
The final component of this work focused on trying to
understand how fasting can induce an increase in gut 5-
HT production [6]. This results in higher plasma 5-HT
levels that are thought to be important for liberating nu-
trient stores such as free fatty acids and glycerol during
periods of fasting [6]. To test our hypothesis that lowered
plasma glucose may be a major driver of this fasting in-
duced increased in EC cell 5-HT production, we exposed
cells in culture to low or high glucose over 24 h. We
observe a doubling of the expression of Tph1, the rate-
limiting enzyme of 5-HT production in non-neuronal cells
that is primarily expressed in EC cells and exclusively
expressed within the gut in these cells. Importantly, in
cells cultured in low glucose, we see functional outcomes
of this transcriptional upregulation in terms of increased
5-HT release from single EC cells. Thus, low plasma
glucose levels, similar to levels observed during periods of
fasting, result in higher 5-HT synthesis and secretion.
Conclusions
Thus, we have demonstrated in this study a complex
interaction of EC cells with the major nutrient glucose.
The pathways by which these cells respond to acute and
chronic changes in glucose availability are vastly different in
a number of ways. Firstly, 5-HT release is increased acutely
by triggering 5-HT secretion via Ca2+-dependent means
while the chronic glucose response augments 5-HT release
in response to low glucose availability. Secondly, the effect
of chronic low glucose exposure occurs through transcrip-
tional alterations regulating 5-HT availability, while the
acute response to high glucose involves the stimulus-
secretion pathway. Thirdly, the concentrations of glucose
underlying these two pathways reflect the acute pathway
occurring due to luminal changes in glucose after a
meal, while the chronic response reflects changes in
plasma glucose levels over a longer time period.
Fig. 5 Chronic low glucose activates 5-HT release through a transcriptional pathway. (a) 24 h in 5 mM glucose causes and increase in Tph1 gene
expression (vs 25 mM glucose, N = 3 preparations n = 9 per group. ** p < 0.01). (b) This results in an increase in 5-HT release events measured with
amperometry and (c) more 5-HT molecules released during stimulation. n = 30 cells for 25 mM and 7 cells for 5 mM. *p < 0.05
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These two response pathways likely serve different but
important homeostatic roles. The release of 5-HT in re-
sponse to an acute nutrient stimulus such as a meal will
be beneficial in a number of intestinal functions of 5-HT
including the modulation of gut motility, gastric empty-
ing and movement of water and solutes across the intes-
tinal wall. An increase in baseline plasma 5-HT levels in
response to fasting and/or chronic low plasma glucose,
however, will trigger the release of stored nutrients such
as free fatty acids and glycerol. This represents an es-
sential survival pathway for the organism during times
of low food availability. Our findings demonstrate that
EC cells release 5-HT via divergent pathways, and that
the outcomes of these responses likely play important
physiological functions.
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